Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (TAK) Stock Overview

Explore Takeda Pharmaceutical Company Limited’s financial performance, market position, analyst ratings, and future outlook.

TAK●NYSE
HealthcareDrug Manufacturers - Specialty & Generic
$18.18
$0.05(0.28%)
U.S. Market opens in 59h 40m

Takeda Pharmaceutical Company Limited (TAK)

Meyka AI Score

Z

Key Financials

Market Cap57.9B
P/E Ratio50.25
EPS (TTM)$1.39
ROE0.02%
Fundamental Analysis

AI Price Forecasts

1 Month$17.49
3 Months$15.65
1 Year Target$17.57

TAK Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Takeda Pharmaceutical Company Limited (NYSE: TAK) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Takeda Pharmaceutical Company Limited's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of TAK on the NYSE shows an RSI of 64.44, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $17.57 for the NYSE listing.

Key metrics behind Takeda Pharmaceutical Company Limited's NYSE-traded stock include a P/E ratio of 50.25 and a market capitalization of 57.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of TAK on the NYSE.

Price Performance (NYSE: TAK)

1-Day Change
0.28%
5-Day Change
3.89%
1-Month Change
5.51%
3-Month Change
10.32%
6-Month Change
-2.57%
Year-to-Date (YTD) Change
16.61%
1-Year Change
18.75%
3-Year Change
20.96%
5-Year Change
7.004%
All-Time (Max) Change
-33.53%

Contact Information

https://www.takeda.com
81 3 3278 2111
1-1, Nihonbashi-Honcho 2-chome, Tokyo, OS, 103-8668

Company Facts

470,290 Employees
IPO DateJan 5, 2010
CountryJP
Actively Trading

Frequently Asked Questions